{"id":"https://openalex.org/W2107057433","doi":"https://doi.org/10.1136/bjo.2007.116616","title":"Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness","display_name":"Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness","alternate_titles":[],"publication_year":2007,"publication_date":"2007-04-12","ids":{"openalex":"https://openalex.org/W2107057433","doi":"https://doi.org/10.1136/bjo.2007.116616","mag":"2107057433","pmid":"https://pubmed.ncbi.nlm.nih.gov/17431015","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1954941"},"language":"en","primary_location":{"id":"doi:10.1136/bjo.2007.116616","doi":"https://doi.org/10.1136/bjo.2007.116616","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2007.116616","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/91/9/1244.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2107057433"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://bjo.bmj.com/content/bjophthalmol/91/9/1244.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072495356","display_name":"James P. Raftery","orcid":"https://orcid.org/0000-0003-1094-8578","observed_orcids":["https://orcid.org/0000-0003-1094-8578"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. Raftery","raw_affiliation_strings":["Wessex Institute for Health R&D, Medical School, University of Southampton, Southampton, UK. raftery@soton.ac.uk","Wessex Institute for Health R&D, Mailpoint 728, Medical School, University of Southampton, Southampton SO16 7PX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wessex Institute for Health R&D, Medical School, University of Southampton, Southampton, UK. raftery@soton.ac.uk","institution_ids":["https://openalex.org/I43439940"]},{"raw_affiliation_string":"Wessex Institute for Health R&D, Mailpoint 728, Medical School, University of Southampton, Southampton SO16 7PX, UK","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004462218","display_name":"Andrew Paul Clegg","orcid":"https://orcid.org/0000-0001-5972-1097","observed_orcids":["https://orcid.org/0000-0001-5972-1097"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Clegg","raw_affiliation_strings":["Wessex Institute for Health R&D, Medical School, University of Southampton, Southampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wessex Institute for Health R&D, Medical School, University of Southampton, Southampton, UK","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Jones","raw_affiliation_strings":["Wessex Institute for Health R&D, Medical School, University of Southampton, Southampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wessex Institute for Health R&D, Medical School, University of Southampton, Southampton, UK","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. C. Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. C. Tan","raw_affiliation_strings":["Wessex Institute for Health R&D, Medical School, University of Southampton, Southampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wessex Institute for Health R&D, Medical School, University of Southampton, Southampton, UK","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072541133","display_name":"Andrew John Lotery","orcid":"https://orcid.org/0000-0001-5541-4305","observed_orcids":["https://orcid.org/0000-0001-5541-4305"]},"institutions":[{"id":"https://openalex.org/I2801388914","display_name":"Southampton General Hospital","ror":"https://ror.org/011cztj49","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801388914","https://openalex.org/I2802965805"]},{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Lotery","raw_affiliation_strings":["University of Southampton, Southampton Eye Unit, Southampton General Hospital, Southampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southampton, Southampton Eye Unit, Southampton General Hospital, Southampton, UK","institution_ids":["https://openalex.org/I2801388914","https://openalex.org/I43439940"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072495356"],"corresponding_institution_ids":["https://openalex.org/I43439940"],"apc_list":null,"apc_paid":null,"fwci":15.5355,"has_fulltext":true,"cited_by_count":162,"citation_normalized_percentile":{"value":0.99480487,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"91","issue":"9","first_page":"1244","last_page":"1246"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.5532000064849854,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.5532000064849854,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.4219000041484833,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/age-related-macular-degeneration","display_name":"age-related macular degeneration","score":0.996999979019165},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8700000047683716},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9229999780654907},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.5389999747276306},{"id":"https://openalex.org/keywords/unlicensed-drug-use","display_name":"unlicensed drug use","score":0.6439999938011169},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.9488239288330078},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9468637704849243},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8510523438453674},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.5840096473693848},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5271812677383423},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.5266107320785522},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.5221479535102844},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.3649722933769226},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2606297731399536},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10012346506118774},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.07781156897544861}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017059","descriptor_name":"Models, Econometric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1136/bjo.2007.116616","doi":"https://doi.org/10.1136/bjo.2007.116616","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2007.116616","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/91/9/1244.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1954941","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1954941/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Ophthalmol","raw_type":"Text"},{"id":"pmid:17431015","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17431015","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of ophthalmology","raw_type":"Comparative Study"},{"id":"pmh:oai:eprints.soton.ac.uk:62552","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/62552/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:open-archive.highwire.org:bjophthalmol:bjo.2007.116616v1","doi":null,"is_oa":false,"landing_page_url":"http://bjo.bmj.com/cgi/content/short/bjo.2007.116616v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:open-archive.highwire.org:bjophthalmol:bjo.2007.116616v2","doi":null,"is_oa":false,"landing_page_url":"http://bjo.bmj.com/cgi/content/short/bjo.2007.116616v2","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.567.9708","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.567.9708","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://bjo.bmj.com/content/91/9/1244.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1136/bjo.2007.116616","doi":"https://doi.org/10.1136/bjo.2007.116616","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2007.116616","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/91/9/1244.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2107057433.pdf","grobid_xml":"https://content.openalex.org/works/W2107057433.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W68981680","https://openalex.org/W1410461568","https://openalex.org/W1521704129","https://openalex.org/W1522623672","https://openalex.org/W1968609549","https://openalex.org/W1975926216","https://openalex.org/W1988700009","https://openalex.org/W2002020452","https://openalex.org/W2014466117","https://openalex.org/W2024548441","https://openalex.org/W2029126623","https://openalex.org/W2033245558","https://openalex.org/W2042261909","https://openalex.org/W2068336290","https://openalex.org/W2077047804","https://openalex.org/W2085712747","https://openalex.org/W2108921960","https://openalex.org/W2124415048","https://openalex.org/W2162119052","https://openalex.org/W2992155016"],"related_works":["https://openalex.org/W3153181018","https://openalex.org/W2126693257","https://openalex.org/W4110361","https://openalex.org/W2343066505","https://openalex.org/W2142475605","https://openalex.org/W1976000255","https://openalex.org/W2804532233","https://openalex.org/W1931298798","https://openalex.org/W2339066515"],"abstract_inverted_index":{"Two":[0],"new":[1],"drugs":[2],"provide":[3],"startling":[4],"benefits":[5],"in":[6,140],"the":[7,44,59,73,91,136],"treatment":[8],"of":[9,19,26,61,95,107,124],"age-related":[10],"macular":[11],"degeneration":[12],"(AMD).":[13],"The":[14,105],"clinical":[15],"and":[16,99,129],"cost":[17,37,45,119],"effectiveness":[18,38],"ranibizumab":[20,65,108],"(Lucentis)":[21],"was":[22,40],"compared":[23],"to":[24,32,42,64,68,75,90,111,117,143],"that":[25],"bevacizumab":[27,62,125,145],"(Avastin),":[28],"which":[29],"costs":[30],"up":[31],"100":[33],"times":[34],"less.":[35],"A":[36],"model":[39],"developed":[41],"assess":[43],"per":[46,80],"quality":[47],"adjusted":[48],"life":[49],"year":[50],"(QALY)":[51],"over":[52],"10":[53],"years.":[54],"For":[55],"predominantly":[56],"classic":[57,103],"AMD,":[58,96],"efficacy":[60],"relative":[63],"would":[66,109],"have":[67,110],"be":[69,112,118,135],"around":[70],"40%":[71],"for":[72,115,146],"latter":[74],"achieve":[76],"30":[77],"k":[78],"pounds":[79],"QALY,":[81],"a":[82],"NICE":[83],"threshold.":[84],"Similar":[85],"but":[86],"worse":[87],"results":[88],"applied":[89],"other":[92],"main":[93],"forms":[94],"minimally":[97],"occult":[98,100],"with":[101],"no":[102],"lesions.":[104],"price":[106],"drastically":[113],"reduced":[114],"it":[116],"effective.":[120],"Continued":[121],"unlicensed":[122],"use":[123],"raises":[126],"ethical,":[127],"legal":[128],"policy":[130],"questions.":[131],"Public":[132],"pressure":[133],"may":[134],"most":[137],"potent":[138],"weapon":[139],"persuading":[141],"Genentech":[142],"license":[144],"AMD.":[147]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2107057433","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
